Advertisement

ADVERTISEMENT

Jolynn Tumolo

News
Initiating Prophylaxis at Younger Age May Preserve Joint Status in Severe Hemophilia A
04/19/2023
Researchers found an association between long-term joint preservation status and patient age at the time of initiating primary prophylaxis for severe hemophilia A.
Researchers found an association between long-term joint preservation status and patient age at the time of initiating primary prophylaxis for severe hemophilia A.
Researchers found an association...
04/19/2023
First Report Managed Care
News
Most Patients With Relapsed/Refractory CLL Respond to Obinutuzumab Combination Therapy
06/23/2023
Researchers studied the efficacy and tolerability of obinutuzumab plus bendamustine in patients with relapsed/refractory chronic lymphocytic leukemia.
Researchers studied the efficacy and tolerability of obinutuzumab plus bendamustine in patients with relapsed/refractory chronic lymphocytic leukemia.
Researchers studied the efficacy...
06/23/2023
First Report Managed Care
News
Zanubrutinib Plus R-CHOP Effective for Non-GCB DLBCL With Extranodal Involvement
08/02/2023
Researchers studied the efficacy and safety of a combination regimen that included zanubrutinib among treatment-naïve patients with non–germinal center B cell–like (non-GCB) diffuse large B-cell lymphoma (DLBCL) with multiple extranodal...
Researchers studied the efficacy and safety of a combination regimen that included zanubrutinib among treatment-naïve patients with non–germinal center B cell–like (non-GCB) diffuse large B-cell lymphoma (DLBCL) with multiple extranodal...
Researchers studied the efficacy...
08/02/2023
First Report Managed Care
News
Heterogeneity of Treatment Effect in MS Trials Should Include Multiple Factors
09/29/2023
The much recognized diversity in outcomes among patients with multiple sclerosis (MS), accounted for by genes, age, and other key patient factors, may extend to therapeutic responses to treatment. Consequently, evaluating possible...
The much recognized diversity in outcomes among patients with multiple sclerosis (MS), accounted for by genes, age, and other key patient factors, may extend to therapeutic responses to treatment. Consequently, evaluating possible...
The much recognized diversity in...
09/29/2023
First Report Managed Care
News
Migraine Tablets Pulled
06/12/2024
Glenmark Pharmaceuticals Inc. USA is recalling 10 lots of rizatriptan benzoate tablets and rizatriptan benzoate orally disintegrating tablets because of an N-nitroso desmethyl rizatriptan impurity.
Glenmark Pharmaceuticals Inc. USA is recalling 10 lots of rizatriptan benzoate tablets and rizatriptan benzoate orally disintegrating tablets because of an N-nitroso desmethyl rizatriptan impurity.
Glenmark Pharmaceuticals Inc....
06/12/2024
Pharmacy Learning Network
News
Class I Recall for Thyroid Medication
03/02/2023
A prescription drug used to treat hypothyroidism is under a Class I recall because the medication may be subpotent.
A prescription drug used to treat hypothyroidism is under a Class I recall because the medication may be subpotent.
A prescription drug used to...
03/02/2023
Pharmacy Learning Network
News
Three Predictors of Shoulder Pain in Nursing Home Workers
06/07/2021
“Redesigning jobs with more breaks and reducing the work demand, and introducing multidisciplinary exercise programs, should be explored further to improve workstyle behaviors and enhance the musculoskeletal health of nursing assistants,”...
“Redesigning jobs with more breaks and reducing the work demand, and introducing multidisciplinary exercise programs, should be explored further to improve workstyle behaviors and enhance the musculoskeletal health of nursing assistants,”...
“Redesigning jobs with more...
06/07/2021
Annals of Long-Term Care
News
AMA Votes Against Insurers Paying Patients to Switch Treatments
07/10/2021
The American Medical Association (AMA) will support state and federal legislation to oppose insurance companies offering financial incentives for patients to switch from a prescribed treatment to a payer-preferred treatment following the...
The American Medical Association (AMA) will support state and federal legislation to oppose insurance companies offering financial incentives for patients to switch from a prescribed treatment to a payer-preferred treatment following the...
The American Medical Association...
07/10/2021
First Report Managed Care
News
Spending on Primary Care in VHA Shows Room for Improvement
08/10/2021
According to new research, primary care accounted for just 8% of spending in the Veterans Health Administration in 2018, suggesting opportunities for improvement.
According to new research, primary care accounted for just 8% of spending in the Veterans Health Administration in 2018, suggesting opportunities for improvement.
According to new research,...
08/10/2021
First Report Managed Care
News
New Guidance Addresses Dupilumab Use in Specific, Common Situations
09/21/2021
An expert panel of dermatologists released new guidance for dupilumab, which included advising patients to continue their treatment for atopic dermatitis while infected with COVID-19.
An expert panel of dermatologists released new guidance for dupilumab, which included advising patients to continue their treatment for atopic dermatitis while infected with COVID-19.
An expert panel of...
09/21/2021
First Report Managed Care

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

December 4 ⁠–⁠ December 5
Great Debates & Updates in Diabetic Foot
December 6 ⁠–⁠ December 7
December 9 ⁠–⁠ December 11
AIBD logo
December 9 ⁠–⁠ December 11
Psych Congress Primary Care Online Series
December 12 ⁠–⁠ December 13
December 14 ⁠–⁠ December 15
February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use